Artwork

Content provided by Arghya. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Arghya or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Post Translational Modifications: Molecular Pathways

25:33
 
Share
 

Manage episode 478931628 series 3661546
Content provided by Arghya. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Arghya or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode of BioBits &Bytes, we decode how cells rewrite the behavior of proteins after translation through post translational modifications (PTMs)—tiny changes that can mean the difference between function and dysfunction. Focusing on polyglutamine (polyQ) diseases like Huntington’s disease, we explore how modifications such as phosphorylation, ubiquitination, and SUMOylation influence the aggregation, toxicity, and fate of proteins with expanded CAG repeats. This molecular fine-tuning not only drives disease progression but also opens new doors for therapeutic targeting.

  continue reading

4 episodes

Artwork
iconShare
 
Manage episode 478931628 series 3661546
Content provided by Arghya. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Arghya or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode of BioBits &Bytes, we decode how cells rewrite the behavior of proteins after translation through post translational modifications (PTMs)—tiny changes that can mean the difference between function and dysfunction. Focusing on polyglutamine (polyQ) diseases like Huntington’s disease, we explore how modifications such as phosphorylation, ubiquitination, and SUMOylation influence the aggregation, toxicity, and fate of proteins with expanded CAG repeats. This molecular fine-tuning not only drives disease progression but also opens new doors for therapeutic targeting.

  continue reading

4 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play